Statement Of Changes In Equity [Abstract]

BerGenBio - Filing #5877180

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	—	22,019,000 NOK	8,899,000 NOK	39,087,000 NOK	—	—	—	52,696,000 NOK	122,702,000 NOK	—	127,476,000 NOK	189,234,000 NOK	—	—	854,000 NOK	—	268,869,000 NOK	—	46,987,000 NOK	88,498,000 NOK	35,780,000 NOK	0 NOK	8,866,000 NOK	43,852,000 NOK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	—	—	139,282,000 NOK	139,282,000 NOK	—	—	—	190,401,000 NOK	—	—	190,401,000 NOK	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	0 NOK	0 NOK	—	—	—	140,531,000 NOK	140,531,000 NOK	0 NOK	—	—	189,234,000 NOK	—	—	189,234,000 NOK	0 NOK	—	0 NOK	—	0 NOK	—	—	—	—	—	—
Issue of equity	122,002,000 NOK	31,111,000 NOK	—	—	—	—	153,113,000 NOK	—	—	—	262,048,000 NOK	—	—	—	2,045,000 NOK	—	260,003,000 NOK	—	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	—	—	—	—	5,709,000 NOK	5,709,000 NOK	—	—	3,135,000 NOK	—	—	—	—	—	—	—	3,135,000 NOK	—	—	—	—	—	—